Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Glenmark Generics Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-eight approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Patent Litigation for Glenmark Generics: See patent lawsuits for Glenmark Generics

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077535-002 Jun 25, 2007 AB RX No No   See Pricing   See Pricing
Glenmark Generics MOMETASONE FUROATE mometasone furoate OINTMENT;TOPICAL 078571-001 May 28, 2008 AB RX No Yes   See Pricing   See Pricing
Glenmark Generics ESZOPICLONE eszopiclone TABLET;ORAL 091166-001 Apr 15, 2014 AB RX No No   See Pricing   See Pricing
Glenmark Generics TOPIRAMATE topiramate TABLET;ORAL 077627-002 Mar 27, 2009 AB RX No No   See Pricing   See Pricing
Glenmark Generics OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 091672-003 Oct 31, 2014 AB RX No No   See Pricing   See Pricing
Glenmark Generics VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 090700-002 Aug 3, 2011 AB RX No Yes   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.